Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

57th AAAAI. Oligodeoxynucleotides.

P Lieberman1

  • 1University of Tennessee College of Medicine, Department of Medicine, 300 Walnut Bend Road 50, Cordova 38018, USA. asthmamemphis@msn.com

Idrugs : the Investigational Drugs Journal
|July 8, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Research abstracts presented at the Eastern Allergy Conference, Palm Beach, Florida, May 6-9, 2010.

Allergy and asthma proceedings·2017
Same author

Identification of alpha-gal sensitivity in patients with a diagnosis of idiopathic anaphylaxis.

Allergy·2017
Same author

Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

Clinical and translational allergy·2017
Same author

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.

Clinical and translational allergy·2017
Same author

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

Clinical and translational allergy·2016
Same author

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.

Allergy·2015
Same journal

Filibuvir, a non-nucleoside NS5B polymerase inhibitor for the potential oral treatment of chronic HCV infection.

IDrugs : the investigational drugs journal·2010
Same journal

Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures.

IDrugs : the investigational drugs journal·2010
Same journal

LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndrome.

IDrugs : the investigational drugs journal·2010
Same journal

Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis.

IDrugs : the investigational drugs journal·2010
Same journal

Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety.

IDrugs : the investigational drugs journal·2010
Same journal

Florbetapir (18F), a PET imaging agent that binds to amyloid plaques for the potential detection of Alzheimer's disease.

IDrugs : the investigational drugs journal·2010
See all related articles

This Allergy and Clinical Immunology meeting highlighted diverse treatments for conditions like asthma and anaphylaxis. Research focused on antihistamines, corticosteroids, and combination therapies, emphasizing their application in rhinitis and asthma management.

Area of Science:

  • Allergy and Clinical Immunology
  • Pharmacology

Background:

  • The meeting covered a broad spectrum of allergic and immunologic conditions.
  • Key areas included asthma, anaphylaxis, rhinitis, food allergy, urticaria, angioedema, and atopic dermatitis.

Purpose of the Study:

  • To present and discuss recent research and clinical trials in Allergy and Clinical Immunology.
  • To emphasize the management of common allergic diseases and the role of various therapeutic agents.

Main Methods:

  • Plenary sessions and in-depth workshops were conducted.
  • Research reports and clinical trials were presented.
  • Focus on pharmacological interventions including antihistamines, corticosteroids, beta-adrenergic agents, leukotriene antagonists, and combination agents.

Related Experiment Videos

Main Results:

  • Over 20 trials on inhaled corticosteroids for rhinitis or asthma were reported.
  • Similar numbers of trials were presented for antihistamine, antileukotriene, and beta-adrenergic therapies.
  • Specific combination agents like montelukast/loratadine for rhinitis and formoterol/budesonide or salmeterol/fluticasone for asthma were highlighted.

Conclusions:

  • The meeting showcased a comprehensive review of current therapeutic strategies in Allergy and Clinical Immunology.
  • Significant emphasis was placed on the efficacy and application of combination therapies for managing allergic respiratory diseases.